Similar Search Results

Price Cap Regulation in the Colombian Pharmaceutical Market : An Impact Evaluation

Bardey, David; Harker, Arturo; Zuluaga, Daniela - 2021

We evaluate the impact of a price cap regulation implemented in the Colombian pharmaceutical market between 2011 and … after regulation) for the eighteen ATC groups. A triple differences model with fixed time effects and cluster errors is used … to identify the impact of this regulation. We find that the price-cap regulation contributed to reduce prices in three of …

Persistent link: https://www.econbiz.de/10013238087

Evaluation of a partial ban of Rx-rebates in Germany using difference-in-differences

Gail, Maximilian M.; Goetz, Georg; Herold, Daniel; … - 2025

strengthen the comprehensive supply of pharmaceuticals to the general population, additional reforms are necessary. …

Persistent link: https://www.econbiz.de/10015202669

Running ahead of Pandemics : Achieving In-Advance Antiviral Drugs

Pannu, Jassi - 2020

Three months into the COVID-19 outbreak caused by a novel strain of coronavirus (SARS-CoV-2), the world is still in …

Persistent link: https://www.econbiz.de/10012837598

COVID-19 vaccination mandates and vaccine uptake

Karajvanov, Alexander K.; Kim, Dongwoo; Lu, Shih En; … - 2021

We evaluate the impact of government mandated proof of vaccination requirements for access to public venues and non-essential businesses on COVID-19 vaccine uptake. We find that the announcement of a mandate is associated with a rapid and significant surge in new vaccinations (more than 60%...

Persistent link: https://www.econbiz.de/10012795392

Covid-19 vaccines, innovation, and intellectual property rights

Cozzi, Guido; Galli, Silvia - 2022

the proliferation of immunity-escaping variants. Therefore governmental rationality around the world would suggest any …

Persistent link: https://www.econbiz.de/10013254230

Calculating Private and Social Returns to COVID-19 Vaccine Innovation

Fink, Carsten - 2023

What is the return to COVID-19 vaccine innovation? This paper seeks to quantify both private and social returns, using available data on commercialized vaccines and certain assumptions about the pandemic’s epidemiological path as well as the economic costs of containment measures. The...

Persistent link: https://www.econbiz.de/10014357767

An assessment of the implications of distribution remuneration and taxation policies on the final prices of prescription medicines : evidence from 35 countries

Leon, Giovanny; Carbonel, Christophe; Rampuria, Aparajit; … - In: The European journal of health economics 26 (2025) 3, pp. 513-536

Persistent link: https://www.econbiz.de/10015394765

What drives innovation? : lessons from COVID-19 R&D

Agarwal, Ruchir; Gaulé, Patrick - 2021

To examine the drivers of innovation, this paper studies the global R&D effort to fight the deadliest diseases and presents four results. We find: (1) global pharmaceutical R&D activity - measured by clinical trials - typically follows the 'law of diminishing efforts': i.e. the elasticity of R&D...

Persistent link: https://www.econbiz.de/10012430944

Does reference pricing drive out generic competition in pharmaceutical markets? : evidence from a policy reform

Brekke, Kurt R.; Canta, Chiara; Straume, Odd Rune - 2022

Policy makers use reference pricing to curb pharmaceutical expenditures by reducing coverage of expensive branded drugs. In a theoretical analysis we show that the net effect of reference pricing is generally ambiguous when accounting for entry by generic producers. Reference pricing shifts...

Persistent link: https://www.econbiz.de/10013285854

The Mitigating Role of Prescription Drug Monitoring Programs in the Abuse of Prescription Drugs

Birk, Erica - 2017

In response to the epidemic of prescription-drug abuse, now 49 US states have passed legislation to establish Prescription Drug Monitoring Programs (PDMPs). These programs track controlled-substance prescribing and usage behavior in an effort to improve patient outcomes and identify and preempt...

Persistent link: https://www.econbiz.de/10012947727